Militello John
SEC insider (Form 3/4/5 filer). CIK 0001662170. Chief Financial Officer at IRulya Therapeutics Inc. (IRLA) and 1 other issuer. 39 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in NEW HAVEN, CT.
Companies Militello John has filed insider reports for
- IRulya Therapeutics Inc. (IRLA): Officer, Chief Financial Officer
- ROCKET PHARMACEUTICALS, INC. (RCKT): Officer, See Remarks
Militello John
CIK: 0001662170
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
27K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
2K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
18K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
18K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
20K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
20K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
10K shares- - May 26, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
DispositionDirectStock Option (Right to Buy)
28.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 |  RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 27,003 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 2,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| May 26, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Disposition Stock Option (Right to Buy) | 28,910 | - | - | Direct |
1-10 of 39 transactions